Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial

被引:93
|
作者
Ibler, Kristina Sophie [1 ,2 ]
Jemec, Gregor B. E. [1 ]
Diepgen, Thomas L. [3 ]
Gluud, Christian [4 ]
Hansen, Jane Lindschou [4 ]
Winkel, Per [4 ]
Thomsen, Simon Francis [2 ]
Agner, Tove [2 ]
机构
[1] Roskilde Hosp, Fac Hlth Sci, Dept Dermatol, DK-4000 Roskilde, Denmark
[2] Bispebjerg Hosp, Fac Hlth Sci, Dept Dermatol, DK-2400 Copenhagen, Denmark
[3] Heidelberg Univ, Dept Social Med Occupat & Environm Dermatol, D-6900 Heidelberg, Germany
[4] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark
来源
关键词
QUALITY-OF-LIFE; KITCHEN EMPLOYEES; PREVENTION; INTERVENTION; SEVERITY; INDEX; DISEASES; DERMATITIS; CLASSIFICATION; MULTICENTER;
D O I
10.1136/bmj.e7822
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate the effect of a secondary prevention programme with education on skin care and individual counselling versus treatment as usual in healthcare workers with hand eczema. Design Randomised, observer blinded parallel group superiority clinical trial. Setting Three hospitals in Denmark. Participants 255 healthcare workers with self reported hand eczema within the past year randomised centrally and stratified by profession, severity of eczema, and hospital. 123 were allocated to the intervention group and 132 to the control group. Interventions Education in skin care and individual counselling based on patch and prick testing and assessment of work and domestic related exposures. The control was treatment as usual. Main outcome measures The primary outcome was clinical severity of disease at five month follow-up measured by scores on the hand eczema severity index. The secondary outcomes were scores on the dermatology life quality index, self evaluated severity of hand eczema, skin protective behaviours, and knowledge of hand eczema from onset to follow-up. Results Follow-up data were available for 247 of 255 participants (97%). At follow-up, the mean score on the hand eczema severity index was significantly lower (improved) in the intervention group than control group: difference of means, unadjusted -3.56 (95% confidence interval -4.92 to -2.14); adjusted -3.47 (-4.80 to -2.14), both P<0.001 for difference. The mean score on the dermatology life quality index was also significantly lower (improved) in the intervention group at follow-up: difference of means: unadjusted -0.78, non-parametric test P=0.003; adjusted -0.92, -1.48 to -0.37). Self evaluated severity and skin protective behaviour by hand washings and wearing of protective gloves were also statistically significantly better in the intervention group, whereas this was not the case for knowledge of hand eczema. Conclusion A secondary prevention programme for hand eczema improved severity and quality of life and had a positive effect on self evaluated severity and skin protective behaviour by hand washings and wearing of protective gloves.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants
    Mathias Lühr Hansen
    Adelina Pellicer
    Christian Gluud
    Eugene Dempsey
    Jonathan Mintzer
    Simon Hyttel-Sorensen
    Anne Marie Heuchan
    Cornelia Hagmann
    Gabriel Dimitriou
    Gerhard Pichler
    Gunnar Naulaers
    Guoqiang Cheng
    Ana Vilan
    Jakub Tkaczyk
    Karen B. Kreutzer
    Monica Fumagalli
    Olivier Claris
    Siv Fredly
    Tomasz Szczapa
    Theis Lange
    Janus Christian Jakobsen
    Gorm Greisen
    [J]. Trials, 20
  • [42] Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients' treatment adherence via electronic monitors and an app versus usual care in Tibet
    Wei, Xiaolin
    Hicks, Joseph Paul
    Pasang, Pande
    Zhang, Zhitong
    Haldane, Victoria
    Liu, Xiaoqiu
    Yin, Tingting
    Wang, Lixia
    Shi, Dachun
    Ge, Shiliang
    Walley, John
    Upshur, Ross
    Hu, Jun
    [J]. TRIALS, 2019, 20 (1)
  • [43] Protocol for a randomised controlled trial to evaluate the effectiveness of improving tuberculosis patients’ treatment adherence via electronic monitors and an app versus usual care in Tibet
    Xiaolin Wei
    Joseph Paul Hicks
    Pande Pasang
    Zhitong Zhang
    Victoria Haldane
    Xiaoqiu Liu
    Tingting Yin
    Lixia Wang
    Dachun Shi
    Shiliang Ge
    John Walley
    Ross Upshur
    Jun Hu
    [J]. Trials, 20
  • [44] Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial
    Mathias Lühr Hansen
    Adelina Pellicer
    Christian Gluud
    Eugene Dempsey
    Jonathan Mintzer
    Simon Hyttel-Sørensen
    Anne Marie Heuchan
    Cornelia Hagmann
    Ebru Ergenekon
    Gabriel Dimitriou
    Gerhard Pichler
    Gunnar Naulaers
    Guoqiang Cheng
    Hercilia Guimarães
    Jakub Tkaczyk
    Karen B. Kreutzer
    Monica Fumagalli
    Olivier Claris
    Petra Lemmers
    Siv Fredly
    Tomasz Szczapa
    Topun Austin
    Janus Christian Jakobsen
    Gorm Greisen
    [J]. Trials, 20
  • [45] Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial
    Hansen, Mathias Luhr
    Pellicer, Adelina
    Gluud, Christian
    Dempsey, Eugene
    Mintzer, Jonathan
    Hyttel-Sorensen, Simon
    Heuchan, Anne Marie
    Hagmann, Cornelia
    Ergenekon, Ebru
    Dimitriou, Gabriel
    Pichler, Gerhard
    Naulaers, Gunnar
    Cheng, Guoqiang
    Guimaraes, Hercilia
    Tkaczyk, Jakub
    Kreutzer, Karen B.
    Fumagalli, Monica
    Claris, Olivier
    Lemmers, Petra
    Fredly, Siv
    Szczapa, Tomasz
    Austin, Topun
    Jakobsen, Janus Christian
    Greisen, Gorm
    [J]. TRIALS, 2019, 20 (01)
  • [46] Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants
    Markus Harboe Olsen
    Mathias Lühr Hansen
    Theis Lange
    Christian Gluud
    Lehana Thabane
    Gorm Greisen
    Janus Christian Jakobsen
    [J]. Trials, 24
  • [47] Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants
    Olsen, Markus Harboe
    Hansen, Mathias Luehr
    Lange, Theis
    Gluud, Christian
    Thabane, Lehana
    Greisen, Gorm
    Jakobsen, Janus Christian
    [J]. TRIALS, 2023, 24 (01)
  • [48] Early preventive exercises versus usual care does not seem to reduce trismus in patients treated with radiotherapy for cancer in the oral cavity or oropharynx: A randomised clinical trial
    Hogdal, Nina
    Juhl, Carsten
    Aadahl, Mette
    Gluud, Christian
    [J]. ACTA ONCOLOGICA, 2015, 54 (01) : 80 - 87
  • [49] Assertive outreach treatment versus care as usual for the treatment of high-need, high-cost alcohol related frequent attenders: study protocol for a randomised controlled trial
    R. Blackwood
    A. Wolstenholme
    A. Kimergård
    S. Fincham-Campbell
    Z. Khadjesari
    S. Coulton
    S. Byford
    P. Deluca
    S. Jennings
    E. Currell
    J. Dunne
    J. O’Toole
    J. Winnington
    E. Finch
    C. Drummond
    [J]. BMC Public Health, 20
  • [50] Assertive outreach treatment versus care as usual for the treatment of high-need, high-cost alcohol related frequent attenders: study protocol for a randomised controlled trial
    Blackwood, R.
    Wolstenholme, A.
    Kimergard, A.
    Fincham-Campbell, S.
    Khadjesari, Z.
    Coulton, S.
    Byford, S.
    Deluca, P.
    Jennings, S.
    Currell, E.
    Dunne, J.
    O'Toole, J.
    Winnington, J.
    Finch, E.
    Drummond, C.
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)